Wednesday, January 11, 2017
AnaptysBio Appoints New CFO
San Diego-based AnaptysBio, which is developing antibodies to treat inflammation, has named a new CFO. AnaptysBio announced this morning that it has appointed Dominic Piscitelli as its new Chief Financial Officer, to head up finance strategy and oversee accounting and SEC reporting. Piscitelli previously was at Medivation, and was part of that firm's acquisition by Pfizer; he also served at Astellas Pharmaceuticals and OSI Pharmaceuticals.